Hide metadata

dc.date.accessioned2020-07-06T19:29:15Z
dc.date.available2020-07-06T19:29:15Z
dc.date.created2020-03-17T15:17:32Z
dc.date.issued2019
dc.identifier.citationStene-Johansen, Ingar Bragadottir, Ragnheidur Petrovski, Beata Petrovski, Goran . Macular Hole Surgery Using Gas Tamponade—An Outcome from the Oslo Retrospective Cross-Sectional Study. Journal of Clinical Medicine. 2019, 8(704), 1-9
dc.identifier.urihttp://hdl.handle.net/10852/77546
dc.description.abstractPurpose: The study aims to determine the anatomical success and functional outcome of pars plana vitrectomy (PPV) for macular holes (MH) performed at a single study center using a consistent procedure of internal limiting membrane (ILM) peeling, SF6 tamponade and 3 days face-down positioning. Methods: A retrospective cross-sectional study involving eyes with MHs which underwent 23- or 25-gauge PPV with or without phacoemulsification and all undergoing a 20% SF6 gas tamponade, follow-up to 6 months postoperatively were included at the Department of Ophthalmology, Oslo University Hospital and University of Oslo, Oslo, Norway (12-month study period between 1 January and 31 December 2015) Pre- and post-operative Best-Corrected Visual Acuity (BCVA) assessment, comprehensive eye examination and intraocular pressure (IOP) measurement. as well as Optical Coherence Tomography to determine the diameter of the MH and its closure were all carried out. Results: 198 consecutive eyes operated for MH (age: 69.4 ± 7.6 years; 1.6:1 female:male ratio) were included; 35.7%/48.6% had symptoms from 3–6/6–48 months; 5.1% had high-grade myopia, 21.5% focal VMT <1500 µm with or without epiretinal membrane (ERM), and 74.0%/26.0% had phakic/pseudophakic status. Primary closure of the MH occurred in 93.3% of the patients. Lens status and length of symptoms showed no significant correlation with closure of the MH. The pre-operative logMAR visual acuity: 0.8 ± 0.3 (median: 0.7; interquartile range (IQR): 0.5–0.8; range: 0.3–1.7), improved significantly post-operatively: 0.4 ± 0.3 (median: 0.3; interquartile range (IQR): 0.1–0.5; range: −0.02–1.2). BCVA improvement of <0.2, 0.2–0.4 and >0.4 was present in 28.3%, 27.3% and 44.4% of the treated patients. No significant median differences could be detected between the duration of the pre-operative symptoms and the pre-/post-operative visual acuity. Increased IOP was measured in 2.6% of the cases day after surgery. Conclusions: Our study found visual outcome not to be dependent upon the length of symptoms in MH patients treated by PPV all undergoing ILM peeling, SF6 tamponade and face-down positioning. The large diameter MH was not a limiting factor to achieve improved post-operative BCVA.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleMacular Hole Surgery Using Gas Tamponade—An Outcome from the Oslo Retrospective Cross-Sectional Study
dc.typeJournal article
dc.creator.authorStene-Johansen, Ingar
dc.creator.authorBragadottir, Ragnheidur
dc.creator.authorPetrovski, Beata
dc.creator.authorPetrovski, Goran
cristin.unitcode185,53,43,11
cristin.unitnameØyeavdelingen
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1802080
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Clinical Medicine&rft.volume=8&rft.spage=1&rft.date=2019
dc.identifier.jtitleJournal of Clinical Medicine
dc.identifier.volume8
dc.identifier.issue5
dc.identifier.doihttps://doi.org/10.3390/jcm8050704
dc.identifier.urnURN:NBN:no-80607
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2077-0383
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/77546/2/Macular%2BHole%2BSurgery%2BUsing%2BGas%2BTamponade.pdf
dc.type.versionPublishedVersion
cristin.articleid704


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International